DNA-framework-based multidimensional molecular classifiers for cancer diagnosis

F Yin, H Zhao, S Lu, J Shen, M Li, X Mao, F Li… - Nature …, 2023 - nature.com
A molecular classification of diseases that accurately reflects clinical behaviour lays the
foundation of precision medicine. The development of in silico classifiers coupled with …

Shaping chromatin states in prostate cancer by pioneer transcription factors

W Hankey, Z Chen, Q Wang - Cancer research, 2020 - AACR
The androgen receptor (AR) is a critical therapeutic target in prostate cancer that responds
to antagonists in primary disease, but inevitably becomes reactivated, signaling onset of the …

MEIS transcription factors in development and disease

D Schulte, D Geerts - Development, 2019 - journals.biologists.com
ABSTRACT MEIS transcription factors are key regulators of embryonic development and
cancer. Research on MEIS genes in the embryo and in stem cell systems has revealed …

SOX2 mediates metabolic reprogramming of prostate cancer cells

L de Wet, A Williams, M Gillard, S Kregel, S Lamperis… - Oncogene, 2022 - nature.com
New strategies are needed to predict and overcome metastatic progression and therapy
resistance in prostate cancer. One potential clinical target is the stem cell transcription factor …

Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer

Y Li, Y Gan, J Liu, J Li, Z Zhou, R Tian, R Sun… - Signal transduction and …, 2022 - nature.com
Oxaliplatin is widely used in the frontline treatment of colorectal cancer (CRC), but an
estimated 50% of patients will eventually stop responding to treatment due to acquired …

Imaging fibroblast activation protein alpha improves diagnosis of metastatic prostate cancer with positron emission tomography

HM Hintz, JP Gallant, DJ Vander Griend… - Clinical Cancer …, 2020 - AACR
Purpose: Metastatic castration-resistant prostate cancer (mCRPC) is a lethal, heterogeneous
disease with few therapeutic strategies that significantly prolong survival. Innovative …

HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway

C Guo, H Chu, Z Gong, B Zhang, C Li, J Chen, L Huang - Life Sciences, 2021 - Elsevier
Aims This study aimed at exploring HOXB13 expression and function in gastric cancer (GC),
and the underlying molecular mechanism. Materials and methods HOXB13 and fat mass …

Inhibition of Senescence‐Associated Genes Rb1 and Meis2 in Adult Cardiomyocytes Results in Cell Cycle Reentry and Cardiac Repair Post–Myocardial Infarction

P Alam, B Haile, M Arif, R Pandey… - Journal of the …, 2019 - Am Heart Assoc
Background Myocardial infarction results in a large‐scale cardiomyocyte loss and heart
failure due to subsequent pathological remodeling. Whereas zebrafish and neonatal mice …

Cancer cells retrace a stepwise differentiation program during malignant progression

S Saghafinia, K Homicsko, A Di Domenico… - Cancer discovery, 2021 - AACR
Pancreatic neuroendocrine tumors (PanNET) comprise two molecular subtypes, relatively
benign islet tumors (IT) and invasive, metastasis-like primary (MLP) tumors. Until now, the …

The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients

R Na, J Wei, CJ Sample, M Gielzak, S Choi… - British journal of …, 2022 - nature.com
Background Recently, a novel HOXB13 variant (X285K) was observed in men of African
descent with prostate cancer (PCa) in Martinique. Little is known about this or other variants …